{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:26:18Z","timestamp":1793895978733,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Heilongjiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["PL2024H127"],"award-info":[{"award-number":["PL2024H127"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302185"],"award-info":[{"award-number":["82302185"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20478"],"award-info":[{"award-number":["U23A20478"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82441008"],"award-info":[{"award-number":["82441008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110156","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:08:00Z","timestamp":1782230880000},"page":"110156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Preclinical evaluation of [68Ga]Ga-MRCP: a potential radiotracer for imaging PD-L1 expression in colorectal cancer"],"prefix":"10.1016","volume":"180","author":[{"given":"Miao","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2026.110156_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110156_bb0010","article-title":"Anti-PD-1\/PD-L1 therapy for colorectal cancer: clinical implications and future considerations","volume":"40","author":"Chen","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bioorg.2026.110156_bb0015","article-title":"Current progress and future perspectives of neoadjuvant anti-PD-1\/PD-L1 therapy for colorectal cancer","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110156_bb0020","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(22)00197-8","article-title":"Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study","volume":"23","author":"Diaz","year":"2022","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110156_bb0025","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.annonc.2022.05.519","article-title":"Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study","volume":"33","author":"Maio","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bioorg.2026.110156_bb0030","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.2147\/OTT.S190168","article-title":"Prognostic and clinicopathological value of PD-L1 in colorectal cancer: a systematic review and meta-analysis","volume":"12","author":"Yang","year":"2019","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.bioorg.2026.110156_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.964442","article-title":"The role of PD-1\/PD-L1 and application of immune-checkpoint inhibitors in human cancers","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110156_bb0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00384-020-03734-4","article-title":"Clinicopathological and prognostic significance of PD-L1 expression in colorectal cancer: a meta-analysis","volume":"36","author":"Wang","year":"2020","journal-title":"Int. J. Color. Dis."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110156_bb0045","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10120-022-01301-0","article-title":"Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy","volume":"25","author":"Yeong","year":"2022","journal-title":"Gastric Cancer"},{"issue":"9","key":"10.1016\/j.bioorg.2026.110156_bb0050","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jtho.2018.05.013","article-title":"PD-L1 immunohistochemistry comparability study in real-life clinical samples: results of blueprint phase 2 project","volume":"13","author":"Tsao","year":"2018","journal-title":"J. Thorac. Oncol."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110156_bb0055","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3390\/ph15060747","article-title":"Development of Radiotracers for Imaging of the PD-1\/PD-L1 Axis","volume":"15","author":"Krutzek","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110156_bb0060","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1007\/s00259-022-05783-z","article-title":"The \u201cdigital biopsy\u201d in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET\/CT","volume":"49","author":"Monaco","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110156_bb0065","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/s41591-018-0255-8","article-title":"89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer","volume":"24","author":"Bensch","year":"2018","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110156_bb0070","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jpha.2022.09.001","article-title":"Development of a radiolabeled site-specific single-domain antibody positron emission tomography probe for monitoring PD-L1 expression in cancer","volume":"12","author":"Chen","year":"2022","journal-title":"J. Pharm. Anal."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110156_bb0075","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1007\/s00259-024-06610-3","article-title":"Development of small-molecular-based radiotracers for PET imaging of PD-L1 expression and guiding the PD-L1 therapeutics","volume":"51","author":"Yang","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110156_bb0080","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1021\/acs.molpharmaceut.3c01151","article-title":"PET imaging of peptide probe Al[18F]F-NOTA-PCP1 for monitoring the engagement of PD-L1 antibodies in Tumors","volume":"21","author":"Zhang","year":"2024","journal-title":"Mol. Pharm."},{"issue":"39","key":"10.1016\/j.bioorg.2026.110156_bb0085","doi-asserted-by":"crossref","first-page":"35638","DOI":"10.1021\/jacs.5c11292","article-title":"Multicyclic peptides targeting PD-L1 for Radiotheranostics: from discovery to clinical proof-of-concept","volume":"147","author":"Cheng","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"14","key":"10.1016\/j.bioorg.2026.110156_bb0090","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1158\/1078-0432.CCR-25-0160","article-title":"68Ga-NK224 PET\/CT for noninvasive evaluation of PD-L1 expression and Intertumor heterogeneity: a translational exploratory study","volume":"31","author":"Zhao","year":"2025","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110156_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202400358","article-title":"Assessment of PD-L1 expression in non-small cell lung cancers using [68Ga]ga-DOTA-WL12 PET\/CT","volume":"8","author":"Wu","year":"2024","journal-title":"Small Methods"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110156_bb0100","article-title":"Cyclic peptides for drug development","volume":"63","author":"Ji","year":"2023","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"18","key":"10.1016\/j.bioorg.2026.110156_bb0105","doi-asserted-by":"crossref","first-page":"12002","DOI":"10.1021\/acs.jmedchem.2c00539","article-title":"Discovery of cyclic peptide inhibitors targeting PD-L1 for Cancer immunotherapy","volume":"65","author":"Fetse","year":"2022","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110156_bb0110","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s40425-019-0705-y","article-title":"Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy","volume":"7","author":"Liu","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bioorg.2026.110156_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107645","article-title":"Development and biological evaluation of 68Ga-labeled peptides for potential application in HER2-positive colorectal cancer","volume":"151","author":"Zhang","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110156_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119984","article-title":"Phage display-identified PD-L1-binding peptides reinvigorate T-cell activity and inhibit tumor progression","volume":"247","author":"Gurung","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioorg.2026.110156_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107810","article-title":"Synthesis and immunotherapy efficacy of a PD-L1 small-molecule inhibitor combined with its 131I-iodide labelled isostructural compound","volume":"153","author":"Lv","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110156_bb0130","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s11426-025-2856-2","article-title":"In silico design and preclinical evaluation of a novel Trop2-targeted peptide tracer for PET imaging of tumors","volume":"69","author":"Fang","year":"2026","journal-title":"Sci. China Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110156_bb0135","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/cells12020258","article-title":"Immunotherapy: recent advances and its future as a neoadjuvant, adjuvant, and primary treatment in colorectal Cancer","volume":"12","author":"Yu","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2026.110156_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1403533","article-title":"Immune checkpoint inhibitors in colorectal cancer: limitation and challenges","volume":"15","author":"Yan","year":"2024","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110156_bb0145","first-page":"133","article-title":"Prevalent Pseudoprogression and Pseudoresidue in patients with rectal cancer treated with neoadjuvant immune checkpoint inhibitors","volume":"21","author":"Xie","year":"2023","journal-title":"J. Natl. Cimpr. Canc. Ne."},{"key":"10.1016\/j.bioorg.2026.110156_bb0150","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3389\/fimmu.2020.01624","article-title":"Colorectal Cancer immunotherapy: options and strategies","volume":"11","author":"Johdi","year":"2020","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.bioorg.2026.110156_bb0155","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1158\/0008-5472.CAN-20-1117","article-title":"High PD-1\/PD-L1 checkpoint interaction infers tumor selection and therapeutic sensitivity to anti-PD-1\/PD-L1 treatment","volume":"80","author":"S\u00e1nchez-Magraner","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110156_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107660","article-title":"Comparative study of [18F]AlF-PAI-PDL1p and [68Ga]Ga-PAI-PDL1p as novel PD-L1 targeting PET probes for tumor imaging","volume":"151","author":"Bai","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2026.110156_bb0165","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1002\/cncr.34228","article-title":"Positron emission tomography molecular imaging-based cancer phenotyping","volume":"128","author":"Jin","year":"2022","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110156_bb0170","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s00259-023-06527-3","article-title":"The discovery and evaluation of [18F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagement","volume":"51","author":"Donnelly","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. I."},{"key":"10.1016\/j.bioorg.2026.110156_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106785","article-title":"A novel 68Ga-labeled cyclic peptide molecular probe based on the computer-aided design for noninvasive imaging of PD-L1 expression in tumors","volume":"140","author":"Ge","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110156_bb0180","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1021\/acs.molpharmaceut.8b00399","article-title":"Peptide-based 68Ga-PET radiotracer for imaging PD-L1 expression in Cancer","volume":"15","author":"De Silva","year":"2018","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110156_bb0185","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1021\/acs.jmedchem.5c03165","article-title":"Helicogenic amino acid increases passive permeability and Oral bioavailability of macrocycles by Preorganizing \u03b3-turn","volume":"69","author":"Raj","year":"2026","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110156_bb0190","first-page":"274","article-title":"Structural optimization and Radiolabeling of EphA2-targeted bicyclic peptides for tumor Theranostics","volume":"69","author":"Liu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110156_bb0195","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.7150\/thno.40482","article-title":"Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity","volume":"10","author":"Deberle","year":"2020","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110156_bb0200","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00259-023-06480-1","article-title":"Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy","volume":"51","author":"Zhu","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. I."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:48:05Z","timestamp":1793893685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826006929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":40,"alternative-id":["S0045206826006929"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110156","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical evaluation of [68Ga]Ga-MRCP: a potential radiotracer for imaging PD-L1 expression in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110156"}}